| Amyotrophic lateral sclerosis MC Kiernan, S Vucic, BC Cheah, MR Turner, A Eisen, O Hardiman, ... The lancet 377 (9769), 942-955, 2011 | 3204 | 2011 |
| Neurological and neuropsychiatric complications of COVID-19 in 153 patients: a UK-wide surveillance study A Varatharaj, N Thomas, MA Ellul, NWS Davies, TA Pollak, EL Tenorio, ... The Lancet Psychiatry 7 (10), 875-882, 2020 | 1635 | 2020 |
| Evidence of widespread cerebral microglial activation in amyotrophic lateral sclerosis: an [11C](R)-PK11195 positron emission tomography study MR Turner, A Cagnin, FE Turkheimer, CCJ Miller, CE Shaw, DJ Brooks, ... Neurobiology of disease 15 (3), 601-609, 2004 | 847 | 2004 |
| Amyotrophic lateral sclerosis-frontotemporal spectrum disorder (ALS-FTSD): Revised diagnostic criteria MJ Strong, S Abrahams, LH Goldstein, S Woolley, P Mclaughlin, ... Amyotrophic lateral sclerosis and frontotemporal degeneration 18 (3-4), 153-174, 2017 | 842 | 2017 |
| Controversies and priorities in amyotrophic lateral sclerosis MR Turner, O Hardiman, M Benatar, BR Brooks, A Chio, M De Carvalho, ... The Lancet Neurology 12 (3), 310-322, 2013 | 648 | 2013 |
| Genome-wide analyses identify KIF5A as a novel ALS gene A Nicolas, KP Kenna, AE Renton, N Ticozzi, F Faghri, R Chia, ... Neuron 97 (6), 1267-1288, 2018 | 633 | 2018 |
| Diagnostic value of cerebrospinal fluid neurofilament light protein in neurology: a systematic review and meta-analysis C Bridel, WN Van Wieringen, H Zetterberg, BM Tijms, CE Teunissen, ... JAMA neurology 76 (9), 1035-1048, 2019 | 614 | 2019 |
| Neurofilament light chain: a prognostic biomarker in amyotrophic lateral sclerosis CH Lu, C Macdonald-Wallis, E Gray, N Pearce, A Petzold, N Norgren, ... Neurology 84 (22), 2247-2257, 2015 | 544 | 2015 |
| Biomarkers in amyotrophic lateral sclerosis MR Turner, MC Kiernan, PN Leigh, K Talbot The Lancet Neurology 8 (1), 94-109, 2009 | 526 | 2009 |
| Prognosis for patients with amyotrophic lateral sclerosis: development and validation of a personalised prediction model HJ Westeneng, TPA Debray, AE Visser, RPA van Eijk, JPK Rooney, ... The Lancet Neurology 17 (5), 423-433, 2018 | 474 | 2018 |
| A proposed staging system for amyotrophic lateral sclerosis JC Roche, R Rojas-Garcia, KM Scott, W Scotton, CE Ellis, R Burman, ... Brain 135 (3), 847-852, 2012 | 444 | 2012 |
| Exome-wide rare variant analysis identifies TUBA4A mutations associated with familial ALS BN Smith, N Ticozzi, C Fallini, AS Gkazi, S Topp, KP Kenna, EL Scotter, ... Neuron 84 (2), 324-331, 2014 | 433 | 2014 |
| A proposal for new diagnostic criteria for ALS JM Shefner, A Al-Chalabi, MR Baker, LY Cui, M de Carvalho, A Eisen, ... Clinical Neurophysiology 131 (8), 2020 | 423 | 2020 |
| Extracellular vesicles in neurodegenerative disease—pathogenesis to biomarkers AG Thompson, E Gray, SM Heman-Ackah, I Mäger, K Talbot, ... Nature Reviews Neurology 12 (6), 346-357, 2016 | 377 | 2016 |
| Variants of the elongator protein 3 ( ELP3 ) gene are associated with motor neuron degeneration CL Simpson, R Lemmens, K Miskiewicz, WJ Broom, VK Hansen, ... Human molecular genetics 18 (3), 472-481, 2009 | 356 | 2009 |
| Corpus callosum involvement is a consistent feature of amyotrophic lateral sclerosis N Filippini, G Douaud, CE Mackay, S Knight, K Talbot, MR Turner Neurology 75 (18), 1645-1652, 2010 | 326 | 2010 |
| NEK1 variants confer susceptibility to amyotrophic lateral sclerosis KP Kenna, PTC Van Doormaal, AM Dekker, N Ticozzi, BJ Kenna, ... Nature genetics 48 (9), 1037-1042, 2016 | 305 | 2016 |
| Diffusion imaging of whole, post-mortem human brains on a clinical MRI scanner KL Miller, CJ Stagg, G Douaud, S Jbabdi, SM Smith, TEJ Behrens, ... Neuroimage 57 (1), 167-181, 2011 | 298 | 2011 |
| Amyotrophic lateral sclerosis in an urban setting: a population based study of inner city London CA Johnston, BR Stanton, MR Turner, R Gray, AHM Blunt, D Butt, ... Journal of neurology 253, 1642-1643, 2006 | 281 | 2006 |
| Integration of structural and functional magnetic resonance imaging in amyotrophic lateral sclerosis G Douaud, N Filippini, S Knight, K Talbot, MR Turner Brain 134 (12), 3470-3479, 2011 | 280 | 2011 |
Kevin TalbotProfessor of Neurology, Oxford UniversityVerified email at ndcn.ox.ac.uk
